Trials / Completed
CompletedNCT00488397
Tigecycline In-Vitro Surveillance Study In Taiwan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7,902 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
In-vitro surveillance study of tigecycline (Tygacil) in Taiwan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | In-vitro testing | This is an in-vitro study thus only one group in the study and there is no intervention treatment nor procedure involved in this study. |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2011-02-01
- Completion
- 2011-02-01
- First posted
- 2007-06-20
- Last updated
- 2011-03-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00488397. Inclusion in this directory is not an endorsement.